Novel regulation of cardiac Na pump via phospholemman

Journal of Molecular and Cellular Cardiology

Volumn 61, Issue , 2013, Pages 83-93

  Pavlovic, Davor ^a   Fuller, William ^b   Shattock, Michael J ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

FXYD 1; Heart; Na K ATPase; Phospholemman; Sodium pump; Sodium regulation

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CALCIUM ION; CYCLIC AMP DEPENDENT PROTEIN KINASE; FXYD PROTEIN; ISOPROTEIN; MEMBRANE PROTEIN; NITRIC OXIDE; PHOSPHATASE; PHOSPHOLEMMAN; PROTEIN KINASE C; REGULATOR PROTEIN; SODIUM; UNCLASSIFIED DRUG;

CALCIUM TRANSPORT; CONGESTIVE HEART FAILURE; ENZYME ACTIVITY; ENZYME STRUCTURE; HEART ARRHYTHMIA; HEART DISEASE; HEART MUSCLE CELL; HEART MUSCLE CONDUCTION DISTURBANCE; HEART MUSCLE CONTRACTILITY; HEART VENTRICLE HYPERTROPHY; HUMAN; NONHUMAN; OXIDATIVE STRESS; PALMITOYLATION; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; SODIUM CELL LEVEL; SODIUM TRANSPORT; SYSTOLIC DYSFUNCTION; TISSUE SPECIFICITY;

ADRENERGIC RECEPTOR; AR; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ET(A); ET-1; FXYD-1; HEART; I-1; INHIBITOR-1; NA/CA EXCHANGER; NA/K ATPASE; NCX; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NO; NOS; PHOSPHATASE-1; PHOSPHOLAMBAN; PHOSPHOLEMMAN; PKA; PKC; PLB; PLM; PP-1; PROTEIN KINASE A; PROTEIN KINASE C; SODIUM PUMP; SODIUM REGULATION;

ANIMALS; HUMANS; LIPOYLATION; MEMBRANE PROTEINS; MYOCARDIAL REPERFUSION INJURY; NITRIC OXIDE; OXIDATIVE STRESS; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEIN KINASES; PROTEIN PROCESSING, POST-TRANSLATIONAL; SIGNAL TRANSDUCTION; SODIUM-CALCIUM EXCHANGER;

EID: 84880326476     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2013.05.002     Document Type: Review

References (154)

1. Skou J.C. The influence of some cations on an adenosine triphosphatase from peripheral nerves. Biochim Biophys Acta 1957, 23:394-401.
2. Morth J.P., Pedersen B.P., Toustrup-Jensen M.S., Sorensen T.L., Petersen J., Andersen J.P., et al. Crystal structure of the sodium-potassium pump. Nature 2007, 450:1043-1049.
3. Shinoda T., Ogawa H., Cornelius F., Toyoshima C. Crystal structure of the sodium-potassium pump at 2.4Å resolution. Nature 2009, 459:446-450.
4. Ogawa H., Shinoda T., Cornelius F., Toyoshima C. Crystal structure of the sodium-potassium pump (Na+, K+-ATPase) with bound potassium and ouabain. Proc Natl Acad Sci U S A 2009, 106:13742-13747.
5. Morth J.P., Poulsen H., Toustrup-Jensen M.S., Schack V.R., Egebjerg J., Andersen J.P., et al. The structure of the Na+, K+-ATPase and mapping of isoform differences and disease-related mutations. Philos Trans R Soc Lond B Biol Sci 2009, 364:217-227.
6. Sweadner K.J., Rael E. The FXYD gene family of small ion transport regulators or channels: cDNA sequence, protein signature sequence, and expression. Genomics 2000, 68:41-56.
7. Kaplan J.H. Biochemistry of Na, K-ATPase. Annu Rev Biochem 2002, 71:511-535.
8. Sweadner K.J. Isozymes of the Na+/K+-ATPase. Biochim Biophys Acta 1989, 988:185-220.
9. Geering K. The functional role of the beta-subunit in the maturation and intracellular transport of Na, K-ATPase. FEBS Lett 1991, 285:189-193.
10. Horisberger J.D., Jaunin P., Good P.J., Rossier B.C., Geering K. Coexpression of alpha 1 with putative beta 3 subunits results in functional Na+/K+ pumps in Xenopus oocytes. Proc Natl Acad Sci U S A 1991, 88:8397-8400.
11. Crambert G., Hasler U., Beggah A.T., Yu C., Modyanov N.N., Horisberger J.D., et al. Transport and pharmacological properties of nine different human Na, K-ATPase isozymes. J Biol Chem 2000, 275:1976-1986.
12. Hensley C.B., Azuma K.K., Tang M.J., McDonough A.A. Thyroid hormone induction of rat myocardial Na(+)-K(+)-ATPase: alpha 1-, alpha 2-, and beta 1-mRNA and -protein levels at steady state. Am J Physiol 1992, 262:C484-C492.
13. Sweadner K.J., Herrera V.L., Amato S., Moellmann A., Gibbons D.K., Repke K.R. Immunologic identification of Na+, K(+)-ATPase isoforms in myocardium. Isoform change in deoxycorticosterone acetate-salt hypertension. Circ Res 1994, 74:669-678.
14. Shamraj O.I., Melvin D., Lingrel J.B. Expression of Na, K-ATPase isoforms in human heart. Biochem Biophys Res Commun 1991, 179:1434-1440.
15. Zahler R., Gilmore-Hebert M., Baldwin J.C., Franco K., Benz E.J. Expression of alpha isoforms of the Na, K-ATPase in human heart. Biochim Biophys Acta 1993, 1149:189-194.
16. Pavlovic D., Fuller W., Shattock M.J. The intracellular region of FXYD1 is sufficient to regulate cardiac Na/K ATPase. FASEB J 2007, 21:1539-1546.
17. Mishra N.K., Peleg Y., Cirri E., Belogus T., Lifshitz Y., Voelker D.R., et al. FXYD proteins stabilize Na, K-ATPase: amplification of specific phosphatidylserine-protein interactions. J Biol Chem 2011, 286:9699-9712.
18. McDonough A.A., Zhang Y., Shin V., Frank J.S. Subcellular distribution of sodium pump isoform subunits in mammalian cardiac myocytes. Am J Physiol 1996, 270:C1221-C1227.
19. James P.F., Grupp I.L., Grupp G., Woo A.L., Askew G.R., Croyle M.L., et al. Identification of a specific role for the Na, K-ATPase alpha 2 isoform as a regulator of calcium in the heart. Mol Cell 1999, 3:555-563.
20. Bossuyt J., Ai X., Moorman J.R., Pogwizd S.M., Bers D.M. Expression and phosphorylation of the NA-pump regulatory subunit phospholemman in heart failure. Circ Res 2005, 97:558-565.
21. Semb S.O., Lunde P.K., Holt E., Tonnessen T., Christensen G., Sejersted O.M. Reduced myocardial Na+, K(+)-pump capacity in congestive heart failure following myocardial infarction in rats. J Mol Cell Cardiol 1998, 30:1311-1328.
22. Tulloch L.B., Howie J., Wypijewski K.J., Wilson C.R., Bernard W.G., Shattock M.J., et al. The inhibitory effect of phospholemman on the sodium pump requires its palmitoylation. J Biol Chem 2011, 286:36020-36031.
23. El-Armouche A., Wittkopper K., Fuller W., Howie J., Shattock M.J., Pavlovic D. Phospholemman-dependent regulation of the cardiac Na/K-ATPase activity is modulated by inhibitor-1 sensitive type-1 phosphatase. FASEB J 2011, 25:4467-4475.
24. Lubarski I., Pihakaski-Maunsbach K., Karlish S.J., Maunsbach A.B., Garty H. Interaction with the Na, K-ATPase and tissue distribution of FXYD5 (related to ion channel). J Biol Chem 2005, 280:37717-37724.
25. Blaustein M.P. Sodium ions, calcium ions, blood pressure regulation, and hypertension: a reassessment and a hypothesis. Am J Physiol 1977, 232:C165-C173.
26. Pierre S.V., Xie Z. The Na, K-ATPase receptor complex: its organization and membership. Cell Biochem Biophys 2006, 46:303-316.
27. Li Z., Xie Z. The Na/K-ATPase/Src complex and cardiotonic steroid-activated protein kinase cascades. Pflugers Arch 2009, 457:635-644.
28. Peng M., Huang L., Xie Z., Huang W.H., Askari A. Partial inhibition of Na+/K+-ATPase by ouabain induces the Ca2+-dependent expressions of early-response genes in cardiac myocytes. J Biol Chem 1996, 271:10372-10378.
29. Dong X.H., Komiyama Y., Nishimura N., Masuda M., Takahashi H. Nanomolar level of ouabain increases intracellular calcium to produce nitric oxide in rat aortic endothelial cells. Clin Exp Pharmacol Physiol 2004, 31:276-283.
30. Lingrel J.B. The physiological significance of the cardiotonic steroid/ouabain-binding site of the Na, K-ATPase. Annu Rev Physiol 2010, 72:395-412.
31. Berry R.G., Despa S., Fuller W., Bers D.M., Shattock M.J. Differential distribution and regulation of mouse cardiac Na+/K+-ATPase alpha1 and alpha2 subunits in T-tubule and surface sarcolemmal membranes. Cardiovasc Res 2007, 73:92-100.
32. Despa S., Bers D.M. Functional analysis of Na+/K+-ATPase isoform distribution in rat ventricular myocytes. Am J Physiol Cell Physiol 2007, 293:C321-C327.
33. Despa S., Lingrel J.B., Bers D.M. Na(+)/K(+)-ATPase alpha2-isoform preferentially modulates Ca2(+) transients and sarcoplasmic reticulum Ca2(+) release in cardiac myocytes. Cardiovasc Res 2012, 95:480-486.
34. Dostanic I., Schultz Jel J., Lorenz J.N., Lingrel J.B. The alpha 1 isoform of Na, K-ATPase regulates cardiac contractility and functionally interacts and co-localizes with the Na/Ca exchanger in heart. J Biol Chem 2004, 279:54053-54061.
35. Mohler P.J., Davis J.Q., Bennett V. Ankyrin-B coordinates the Na/K ATPase, Na/Ca exchanger, and InsP3 receptor in a cardiac T-tubule/SR microdomain. PLoS Biol 2005, 3:e423.
36. Neubauer S., Newell J.B., Ingwall J.S. Metabolic consequences and predictability of ventricular fibrillation in hypoxia. A 31P- and 23Na-nuclear magnetic resonance study of the isolated rat heart. Circulation 1992, 86:302-310.
37. Tani M., Neely J.R. Role of intracellular Na+ in Ca2+ overload and depressed recovery of ventricular function of reperfused ischemic rat hearts. Possible involvement of H+-Na+ and Na+-Ca2+ exchange. Circ Res 1989, 65:1045-1056.
38. Pogwizd S.M., Sipido K.R., Verdonck F., Bers D.M. Intracellular Na in animal models of hypertrophy and heart failure: contractile function and arrhythmogenesis. Cardiovasc Res 2003, 57:887-896.
39. Pieske B., Houser S.R. [Na+]i handling in the failing human heart. Cardiovasc Res 2003, 57:874-886.
40. Pieske B., Maier L.S., Piacentino V., Weisser J., Hasenfuss G., Houser S. Rate dependence of [Na+]i and contractility in nonfailing and failing human myocardium. Circulation 2002, 106:447-453.
41. Verdonck F., Volders P.G., Vos M.A., Sipido K.R. Increased Na+ concentration and altered Na/K pump activity in hypertrophied canine ventricular cells. Cardiovasc Res 2003, 57:1035-1043.
42. Verdonck F., Volders P.G., Vos M.A., Sipido K.R. Intracellular Na+ and altered Na+ transport mechanisms in cardiac hypertrophy and failure. J Mol Cell Cardiol 2003, 35:5-25.
43. Hasenfuss G., Maier L.S. Mechanism of action of the new anti-ischemia drug ranolazine. Clin Res Cardiol 2008, 97:222-226.
44. Pike M.M., Luo C.S., Clark M.D., Kirk K.A., Kitakaze M., Madden M.C., et al. NMR measurements of Na+ and cellular energy in ischemic rat heart: role of Na(+)-H+ exchange. Am J Physiol 1993, 265:H2017-H2026.
45. Fuller W., Parmar V., Eaton P., Bell J.R., Shattock M.J. Cardiac ischemia causes inhibition of the Na/K ATPase by a labile cytosolic compound whose production is linked to oxidant stress. Cardiovasc Res 2003, 57:1044-1051.
46. van Echteld C.J., Kirkels J.H., Eijgelshoven M.H., van der Meer P., Ruigrok T.J. Intracellular sodium during ischemia and calcium-free perfusion: a 23Na NMR study. J Mol Cell Cardiol 1991, 23:297-307.
47. Despa S., Islam M.A., Weber C.R., Pogwizd S.M., Bers D.M. Intracellular Na(+) concentration is elevated in heart failure but Na/K pump function is unchanged. Circulation 2002, 105:2543-2548.
48. Undrovinas A.I., Maltsev V.A., Sabbah H.N. Repolarization abnormalities in cardiomyocytes of dogs with chronic heart failure: role of sustained inward current. Cell Mol Life Sci 1999, 55:494-505.
49. Valdivia C.R., Chu W.W., Pu J., Foell J.D., Haworth R.A., Wolff M.R., et al. Increased late sodium current in myocytes from a canine heart failure model and from failing human heart. J Mol Cell Cardiol 2005, 38:475-483.
50. Baartscheer A., Schumacher C.A., van Borren M.M., Belterman C.N., Coronel R., Opthof T., et al. Chronic inhibition of Na+/H+-exchanger attenuates cardiac hypertrophy and prevents cellular remodeling in heart failure. Cardiovasc Res 2005, 65:83-92.
51. Baartscheer A., Schumacher C.A., van Borren M.M., Belterman C.N., Coronel R., Fiolet J.W. Increased Na+/H+-exchange activity is the cause of increased [Na+]i and underlies disturbed calcium handling in the rabbit pressure and volume overload heart failure model. Cardiovasc Res 2003, 57:1015-1024.
52. Allen P.D., Schmidt T.A., Marsh J.D., Kjeldsen K. Na, K-ATPase expression in normal and failing human left ventricle. Basic Res Cardiol 1992, 87(Suppl. 1):87-94.
53. Schwinger R.H., Wang J., Frank K., Muller-Ehmsen J., Brixius K., McDonough A.A., et al. Reduced sodium pump alpha1, alpha3, and beta1-isoform protein levels and Na+, K+-ATPase activity but unchanged Na+-Ca2+ exchanger protein levels in human heart failure. Circulation 1999, 99:2105-2112.
54. Lee C.O., Dagostino M. Effect of strophanthidin on intracellular Na ion activity and twitch tension of constantly driven canine cardiac Purkinje fibers. Biophys J 1982, 40:185-198.
55. Bers D.M., Despa S. Cardiac myocytes Ca2+ and Na+ regulation in normal and failing hearts. J Pharmacol Sci 2006, 100:315-322.
56. Shattock M.J. Phospholemman: its role in normal cardiac physiology and potential as a druggable target in disease. Curr Opin Pharmacol 2009, 9:160-166.
57. Heineke J., Molkentin J.D. Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Mol Cell Biol 2006, 7:589-600.
58. Palmer C.J., Scott B.T., Jones L.R. Purification and complete sequence determination of the major plasma membrane substrate for cAMP-dependent protein kinase and protein kinase C in myocardium. J Biol Chem 1991, 266:11126-11130.
59. Mercer R.W., Biemesderfer D., Bliss D.P., Collins J.H., Forbush B. Molecular cloning and immunological characterization of the gamma polypeptide, a small protein associated with the Na, K-ATPase. J Cell Biol 1993, 121:579-586.
60. Morrison B.W., Moorman J.R., Kowdley G.C., Kobayashi Y.M., Jones L.R., Leder P. Mat-8, a novel phospholemman-like protein expressed in human breast tumors, induces a chloride conductance in Xenopus oocytes. J Biol Chem 1995, 270:2176-2182.
61. Attali B., Latter H., Rachamim N., Garty H. A corticosteroid-induced gene expressing an "IsK-like" K+channel activity in Xenopus oocytes. Proc Natl Acad Sci U S A 1995, 92:6092-6096.
62. Fu X., Kamps M.P. E2a-Pbx1 induces aberrant expression of tissue-specific and developmentally regulated genes when expressed in NIH 3T3 fibroblasts. Mol Cell Biol 1997, 17:1503-1512.
63. Yamaguchi F., Yamaguchi K., Tai Y., Sugimoto K., Tokuda M. Molecular cloning and characterization of a novel phospholemman-like protein from rat hippocampus. Brain Res Mol Brain Res 2001, 86:189-192.
64. Beguin P., Crambert G., Monnet-Tschudi F., Uldry M., Horisberger J.D., Garty H., et al. FXYD7 is a brain-specific regulator of Na, K-ATPase alpha 1-beta isozymes. EMBO J 2002, 21:3264-3273.
65. Crowell K.J., Franzin C.M., Koltay A., Lee S., Lucchese A.M., Snyder B.C., et al. Expression and characterization of the FXYD ion transport regulators for NMR structural studies in lipid micelles and lipid bilayers. Biochim Biophys Acta 2003, 1645:15-21.
66. Therien A.G., Deber C.M. Oligomerization of a peptide derived from the transmembrane region of the sodium pump gamma subunit: effect of the pathological mutation G41R. J Mol Biol 2002, 322:583-50.
67. Moorman J.R., Palmer C.J., John J.E., Durieux M.E., Jones L.R. Phospholemman expression induces a hyperpolarization-activated chloride current in Xenopus oocytes. J Biol Chem 1992, 267:14551-14554.
68. Beguin P., Wang X., Firsov D., Puoti A., Claeys D., Horisberger J.D., et al. The gamma subunit is a specific component of the Na, K-ATPase and modulates its transport function. EMBO J 1997, 16:4250-4260.
69. Arystarkhova E., Donnet C., Asinovski N.K., Sweadner K.J. Differential regulation of renal Na, K-ATPase by splice variants of the gamma subunit. J Biol Chem 2002, 277:10162-10172.
70. Pu H.X., Scanzano R., Blostein R. Distinct regulatory effects of the Na, K-ATPase gamma subunit. J Biol Chem 2002, 277:20270-20276.
71. Geering K. FXYD proteins: new regulators of Na-K-ATPase. Am J Physiol Renal Physiol 2006, 290:F241-F250.
72. Bogaev R.C., Jia L.G., Kobayashi Y.M., Palmer C.J., Mounsey J.P., Moorman J.R., et al. Gene structure and expression of phospholemman in mouse. Gene 2001, 271:69-79.
73. Wetzel R.K., Sweadner K.J. Phospholemman expression in extraglomerular mesangium and afferent arteriole of the juxtaglomerular apparatus. Am J Physiol Renal Physiol 2003, 285:F121-F129.
74. Feschenko M.S., Donnet C., Wetzel R.K., Asinovski N.K., Jones L.R., Sweadner K.J. Phospholemman, a single-span membrane protein, is an accessory protein of Na, K-ATPase in cerebellum and choroid plexus. J Neurosci 2003, 23:2161-2169.
75. Moorman J.R., Ackerman S.J., Kowdley G.C., Griffin M.P., Mounsey J.P., Chen Z., et al. Unitary anion currents through phospholemman channel molecules. Nature 1995, 377:737-740.
76. Bossuyt J., Despa S., Martin J.L., Bers D.M. Phospholemman phosphorylation alters its fluorescence resonance energy transfer with the Na/K-ATPase pump. J Biol Chem 2006, 281:32765-32773.
77. Beevers A.J., Kukol A. Secondary structure, orientation, and oligomerization of phospholemman, a cardiac transmembrane protein. Protein Sci 2006, 15:1127-1132.
78. Bell J.R., Lloyd D., Curl C.L., Delbridge L.M., Shattock M.J. Cell volume control in phospholemman (PLM) knockout mice: do cardiac myocytes demonstrate a regulatory volume decrease and is this influenced by deletion of PLM?. Exp Physiol 2009, 94:330-343.
79. Wypijewski K.J., Howie J., Reilly L., Tulloch L.B., Aughton K.L., McLatchie L.M., et al. A separate pool of cardiac phospholemman that does not regulate or associate with the sodium pump: multimers of phospholemman in ventricular muscle. J Biol Chem May 10 2013, 288(19):13808-13820.
80. Fuller W., Howie J., McLatchie L.M., Weber R.J., Hastie C.J., Burness K., et al. FXYD1 phosphorylation in vitro and in adult rat cardiac myocytes: threonine 69 is a novel substrate for protein kinase C. Am J Physiol Cell Physiol 2009, 296:C1346-C1355.
81. Walaas S.I., Czernik A.J., Olstad O.K., Sletten K., Walaas O. Protein kinase C and cyclic AMP-dependent protein kinase phosphorylate phospholemman, an insulin and adrenaline-regulated membrane phosphoprotein, at specific sites in the carboxy terminal domain. Biochem J 1994, 304(Pt 2):635-640.
82. Bossuyt J., Despa S., Han F., Hou Z., Robia S.L., Lingrel J.B., et al. Isoform specificity of the Na/K-ATPase association and regulation by phospholemman. J Biol Chem 2009, 284:26749-26757.
83. Crambert G., Fuzesi M., Garty H., Karlish S., Geering K. Phospholemman (FXYD1) associates with Na, K-ATPase and regulates its transport properties. Proc Natl Acad Sci U S A 2002, 99:11476-11481.
84. Fuller W., Eaton P., Bell J.R., Shattock M.J. Ischemia-induced phosphorylation of phospholemman directly activates rat cardiac Na/K-ATPase. FASEB J 2004, 18:197-199.
85. Lindzen M., Gottschalk K.E., Fuzesi M., Garty H., Karlish S.J. Structural interactions between FXYD proteins and Na+, K+-ATPase: alpha/beta/FXYD subunit stoichiometry and cross-linking. J Biol Chem 2006, 281:5947-5955.
86. Khafaga M., Bossuyt J., Mamikonian L., Li J.C., Lee L.L., Yarov-Yarovoy V., et al. Na(+)/K(+)-ATPase E960 and phospholemman F28 are critical for their functional interaction. Proc Natl Acad Sci U S A 2012, 109:20756-20761.
87. Franzin C.M., Gong X.M., Thai K., Yu J., Marassi F.M. NMR of membrane proteins in micelles and bilayers: the FXYD family proteins. Methods 2007, 41:398-408.
88. Teriete P., Franzin C.M., Choi J., Marassi F.M. Structure of the Na, K-ATPase regulatory protein FXYD1 in micelles. Biochemistry 2007, 46:6774-6783.
89. Despa S., Bossuyt J., Han F., Ginsburg K.S., Jia L.G., Kutchai H., et al. Phospholemman-phosphorylation mediates the beta-adrenergic effects on Na/K pump function in cardiac myocytes. Circ Res 2005, 97:252-259.
90. Han F., Bossuyt J., Despa S., Tucker A.L., Bers D.M. Phospholemman phosphorylation mediates the protein kinase C-dependent effects on Na+/K+ pump function in cardiac myocytes. Circ Res 2006, 99:1376-1383.
91. Han F., Tucker A.L., Lingrel J.B., Despa S., Bers D.M. Extracellular potassium dependence of the Na+-K+-ATPase in cardiac myocytes: isoform specificity and effect of phospholemman. Am J Physiol Cell Physiol 2009, 297:C699-C705.
92. Lifshitz Y., Lindzen M., Garty H., Karlish S.J. Functional interactions of phospholemman (PLM) (FXYD1) with Na+, K+-ATPase. Purification of alpha1/beta1/PLM complexes expressed in Pichia pastoris. J Biol Chem 2006, 281:15790-15799.
93. Silverman B., Fuller W., Eaton P., Deng J., Moorman J.R., Cheung J.Y., et al. Serine 68 phosphorylation of phospholemman: acute isoform-specific activation of cardiac Na/K ATPase. Cardiovasc Res 2005, 65:93-103.
94. Zhang X.Q., Moorman J.R., Ahlers B.A., Carl L.L., Lake D.E., Song J., et al. Phospholemman overexpression inhibits Na+-K+-ATPase in adult rat cardiac myocytes: relevance to decreased Na+ pump activity in postinfarction myocytes. J Appl Physiol 2006, 100:212-220.
95. Bibert S., Roy S., Schaer D., Horisberger J.D., Geering K. Phosphorylation of phospholemman (FXYD1) by protein kinases A and C modulates distinct Na, K-ATPase isozymes. J Biol Chem 2008, 283:476-486.
96. Glitsch H.G., Krahn T., Pusch H., Suleymanian M. Effect of isoprenaline on active Na transport in sheep cardiac Purkinje fibres. Pflugers Arch 1989, 415:88-94.
97. Desilets M., Baumgarten C.M. Isoproterenol directly stimulates the Na+-K+ pump in isolated cardiac myocytes. Am J Physiol 1986, 251:H218-H225.
98. Kockskamper J., Erlenkamp S., Glitsch H.G. Activation of the cAMP-protein kinase A pathway facilitates Na+ translocation by the Na+-K+ pump in guinea-pig ventricular myocytes. J Physiol 2000, 523(Pt 3):561-574.
99. Gao J., Cohen I.S., Mathias R.T., Baldo G.J. Regulation of the beta-stimulation of the Na(+)-K+ pump current in guinea-pig ventricular myocytes by a cAMP-dependent PKA pathway. J Physiol 1994, 477(Pt 3):373-380.
100. White C.N., Liu C.C., Garcia A., Hamilton E.J., Chia K.K., Figtree G.A., et al. Activation of cAMP-dependent signaling induces oxidative modification of the cardiac Na+-K+ pump and inhibits its activity. J Biol Chem 2010, 285:13712-13720.
101. Gao J., Cohen I.S., Mathias R.T., Baldo G.J. The inhibitory effect of beta-stimulation on the Na/K pump current in guinea pig ventricular myocytes is mediated by a cAMP-dependent PKA pathway. Pflugers Arch 1998, 435:479-484.
102. Gao J., Mathias R.T., Cohen I.S., Baldo G.J. Isoprenaline, Ca2+ and the Na(+)-K+ pump in guinea-pig ventricular myocytes. J Physiol 1992, 449:689-704.
103. Poulsen H., Morth P., Egebjerg J., Nissen P. Phosphorylation of the Na+, K+-ATPase and the H+, K+-ATPase. FEBS Lett 2010, 584:2589-2595.
104. Despa S., Tucker A.L., Bers D.M. Phospholemman-mediated activation of Na/K-ATPase limits [Na]i and inotropic state during beta-adrenergic stimulation in mouse ventricular myocytes. Circulation 2008, 117:1849-1855.
105. Wang J., Gao E., Song J., Zhang X.Q., Li J., Koch W.J., et al. Phospholemman and beta-adrenergic stimulation in the heart. Am J Physiol Heart Circ Physiol 2010, 298:H807-H815.
106. Gao J., Mathias R.T., Cohen I.S., Wang Y., Sun X., Baldo G.J. Activation of PKC increases Na+-K+ pump current in ventricular myocytes from guinea pig heart. Pflugers Arch 1999, 437:643-651.
107. Wang Y., Gao J., Mathias R.T., Cohen I.S., Sun X., Baldo G.J. alpha-Adrenergic effects on Na+-K+ pump current in guinea-pig ventricular myocytes. J Physiol 1998, 509(Pt 1):117-128.
108. Lundmark J.L., Ramasamy R., Vulliet P.R., Schaefer S. Chelerythrine increases Na-K-ATPase activity and limits ischemic injury in isolated rat hearts. Am J Physiol 1999, 277:H999-H1006.
109. Buhagiar K.A., Hansen P.S., Bewick N.L., Rasmussen H.H. Protein kinase Cepsilon contributes to regulation of the sarcolemmal Na(+)-K(+) pump. Am J Physiol Cell Physiol 2001, 281:C1059-C1063.
110. White C.N., Figtree G.A., Liu C.C., Garcia A., Hamilton E.J., Chia K.K., et al. Angiotensin II inhibits the Na+-K+ pump via PKC-dependent activation of NADPH oxidase. Am J Physiol Cell Physiol 2009, 296:C693-C700.
111. Cheng S.X., Aizman O., Nairn A.C., Greengard P., Aperia A. [Ca2+]i determines the effects of protein kinases A and C on activity of rat renal Na+, K+-ATPase. J Physiol 1999, 518(Pt 1):37-46.
112. Pavlovic D., Hall A.R., Kennington E.J., Aughton K., Boguslavskyii A., Fuller W., et al. Nitric oxide regulates cardiac intracellular Na and Ca by modulating Na/K ATPase via PKCepsilon and phospholemman-dependent mechanism. J Mol Cell Cardiol Apr 20 2013, (Epub ahead of print, pii:S0022-2828(13)00144-2).
113. Gao J., Wymore R., Wymore R.T., Wang Y., McKinnon D., Dixon J.E., et al. Isoform-specific regulation of the sodium pump by alpha- and beta-adrenergic agonists in the guinea-pig ventricle. J Physiol 1999, 516(Pt 2):377-383.
114. Khan S.A., Skaf M.W., Harrison R.W., Lee K., Minhas K.M., Kumar A., et al. Nitric oxide regulation of myocardial contractility and calcium cycling: independent impact of neuronal and endothelial nitric oxide synthases. Circ Res 2003, 92:1322-1329.
115. Dedkova E.N., Wang Y.G., Ji X., Blatter L.A., Samarel A.M., Lipsius S.L. Signalling mechanisms in contraction-mediated stimulation of intracellular NO production in cat ventricular myocytes. J Physiol 2007, 580:327-345.
116. Kang D.G., Kim J.W., Lee J. Effects of nitric oxide synthesis inhibition on the Na, K-ATPase activity in the kidney. Pharmacol Res 2000, 41:123-127.
117. Liang M., Knox F.G. Nitric oxide reduces the molecular activity of Na+, K+-ATPase in opossum kidney cells. Kidney Int 1999, 56:627-634.
118. Varela M., Herrera M., Garvin J.L. Inhibition of Na-K-ATPase in thick ascending limbs by NO depends on O2- and is diminished by a high-salt diet. Am J Physiol Renal Physiol 2004, 287:F224-F230.
119. McKee M., Scavone C., Nathanson J.A. Nitric oxide, cGMP, and hormone regulation of active sodium transport. Proc Natl Acad Sci U S A 1994, 91:12056-12060.
120. Ellis D.Z., Nathanson J.A., Rabe J., Sweadner K.J. Carbachol and nitric oxide inhibition of Na, K-ATPase activity in bovine ciliary processes. Invest Ophthalmol Vis Sci 2001, 42:2625-2631.
121. Ellis D.Z., Nathanson J.A., Sweadner K.J. Carbachol inhibits Na(+)-K(+)-ATPase activity in choroid plexus via stimulation of the NO/cGMP pathway. Am J Physiol Cell Physiol 2000, 279:C1685-C1693.
122. William M., Vien J., Hamilton E., Garcia A., Bundgaard H., Clarke R.J., et al. The nitric oxide donor sodium nitroprusside stimulates the Na+-K+ pump in isolated rabbit cardiac myocytes. J Physiol 2005, 565:815-825.
123. White C.N., Hamilton E.J., Garcia A., Wang D., Chia K.K., Figtree G.A., et al. Opposing effects of coupled and uncoupled NOS activity on the Na+-K+ pump in cardiac myocytes. Am J Physiol Cell Physiol 2008, 294:C572-C578.
124. Gupta S., McArthur C., Grady C., Ruderman N.B. Stimulation of vascular Na(+)-K(+)-ATPase activity by nitric oxide: a cGMP-independent effect. Am J Physiol 1994, 266:H2146-H2151.
125. Gupta S., McArthur C., Grady C., Ruderman N.B. Role of endothelium-derived nitric oxide in stimulation of Na(+)-K(+)-ATPase activity by endothelin in rabbit aorta. Am J Physiol 1994, 266:H577-H582.
126. Chen S.J., Chen K.H., Webb R.C., Yen M.H., Wu C.C. Abnormal activation of Na+-K+ pump in aortas from rats with endotoxaemia. Naunyn Schmiedebergs Arch Pharmacol 2003, 368:57-62.
127. Vlkovicova J., Javorkova V., Mezesova L., Pechanova O., Vrbjar N. Regulatory role of nitric oxide on the cardiac Na, K-ATPase in hypertension. Physiol Res 2008, 57(Suppl. 2):S15-S22.
128. Pavlovic D., Hall A., Fuller W., Shattock M.J. Rapid pacing stimulates Na/K ATPase in rat ventricular myocytes via a nitric oxide and phospholemman-dependent mechanism. Circulation 2010, 122.
129. Floyd R.V., Wray S., Martin-Vasallo P., Mobasheri A. Differential cellular expression of FXYD1 (phospholemman) and FXYD2 (gamma subunit of Na, K-ATPase) in normal human tissues: a study using high density human tissue microarrays. Ann Anat 2010, 192:7-16.
130. Neumann J., Maas R., Boknik P., Jones L.R., Zimmermann N., Scholz H. Pharmacological characterization of protein phosphatase activities in preparations from failing human hearts. J Pharmacol Exp Ther 1999, 289:188-193.
131. MacDougall L.K., Jones L.R., Cohen P. Identification of the major protein phosphatases in mammalian cardiac muscle which dephosphorylate phospholamban. Eur J Biochem 1991, 196:725-734.
132. Oliver C.J., Shenolikar S. Physiologic importance of protein phosphatase inhibitors. Front Biosci 1998, 3:D961-D972.
133. Carr A.N., Schmidt A.G., Suzuki Y., del Monte F., Sato Y., Lanner C., et al. Type 1 phosphatase, a negative regulator of cardiac function. Mol Cell Biol 2002, 22:4124-4135.
134. Nicolaou P., Hajjar R.J., Kranias E.G. Role of protein phosphatase-1 inhibitor-1 in cardiac physiology and pathophysiology. J Mol Cell Cardiol 2009, 47:365-371.
135. Herzig S., Neumann J. Effects of serine/threonine protein phosphatases on ion channels in excitable membranes. Physiol Rev 2000, 80:173-210.
136. Wittkopper K., Eschenhagen T., El-Armouche A. Phosphatase-1-inhibitor-1: amplifier or attenuator of catecholaminergic stress?. Basic Res Cardiol 2010, 105:569-571.
137. El-Armouche A., Wittkopper K., Degenhardt F., Weinberger F., Didie M., Melnychenko I., et al. Phosphatase inhibitor-1-deficient mice are protected from catecholamine-induced arrhythmias and myocardial hypertrophy. Cardiovasc Res 2008, 80:396-406.
138. Neumann J., Eschenhagen T., Jones L.R., Linck B., Schmitz W., Scholz H., et al. Increased expression of cardiac phosphatases in patients with end-stage heart failure. J Mol Cell Cardiol 1997, 29:265-272.
139. Bibert S., Liu C.C., Figtree G.A., Garcia A., Hamilton E.J., Marassi F.M., et al. FXYD proteins reverse inhibition of the Na+-K+ pump mediated by glutathionylation of its beta1 subunit. J Biol Chem 2011, 286:18562-18572.
140. Fuller W., Tulloch L.B., Shattock M.J., Calaghan S.C., Howie J., Wypijewski K.J. Regulation of the cardiac sodium pump. Cell Mol Life Sci 2013, 70:1357-1380.
141. Cornelius F., Mahmmoud Y.A. Functional modulation of the sodium pump: the regulatory proteins "Fixit". News Physiol Sci 2003, 18:119-124.
142. Shattock M.J., Matsuura H. Measurement of Na(+)-K+ pump current in isolated rabbit ventricular myocytes using the whole-cell voltage-clamp technique. Inhibition of the pump by oxidant stress. Circ Res 1993, 72:91-101.
143. Haddock P.S., Shattock M.J., Hearse D.J. Modulation of cardiac Na(+)-K+ pump current: role of protein and nonprotein sulfhydryl redox status. Am J Physiol 1995, 269:H297-H307.
144. Petrushanko I.Y., Yakushev S., Mitkevich V.A., Kamanina Y.V., Ziganshin R.H., Meng X., et al. S-glutathionylation of the Na, K-ATPase catalytic alpha subunit is a determinant of the enzyme redox sensitivity. J Biol Chem 2012, 287:32195-32205.
145. Figtree G.A., Liu C.C., Bibert S., Hamilton E.J., Garcia A., White C.N., et al. Reversible oxidative modification: a key mechanism of Na+-K+ pump regulation. Circ Res 2009, 105:185-193.
146. Brennan J.P., Bardswell S.C., Burgoyne J.R., Fuller W., Schroder E., Wait R., et al. Oxidant-induced activation of type I protein kinase A is mediated by RI subunit interprotein disulfide bond formation. J Biol Chem 2006, 281:21827-21836.
147. Burgoyne J.R., Eaton P. Oxidant sensing by protein kinases a and g enables integration of cell redox state with phosphoregulation. Sensors (Basel). 2010, 10:2731-2751.
148. Hale S.L., Kloner R.A. The antianginal agent, ranolazine, reduces myocardial infarct size but does not alter anatomic no-reflow or regional myocardial blood flow in ischemia/reperfusion in the rabbit. J Cardiovasc Pharmacol Ther 2008, 13:226-232.
149. Morrow D.A., Scirica B.M., Karwatowska-Prokopczuk E., Murphy S.A., Budaj A., Varshavsky S., et al. Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial. JAMA 2007, 297:1775-1783.
150. Swift F., Birkeland J.A., Tovsrud N., Enger U.H., Aronsen J.M., Louch W.E., et al. Altered Na+/Ca2+-exchanger activity due to downregulation of Na+/K+-ATPase alpha2-isoform in heart failure. Cardiovasc Res 2008, 78:71-78.
151. Rasmussen H.H., Figtree G. "Don't flog the heart!" - development of specific drug therapies for heart failure. Crit Care Resusc 2007, 9:364-369.
152. Liu T., O'Rourke B. Enhancing mitochondrial Ca2+ uptake in myocytes from failing hearts restores energy supply and demand matching. Circ Res 2008, 103:279-288.
153. Liu T., O'Rourke B. Regulation of mitochondrial Ca2+ and its effects on energetics and redox balance in normal and failing heart. J Bioenerg Biomembr 2009, 41:127-132.
154. Maack C., Cortassa S., Aon M.A., Ganesan A.N., Liu T., O'Rourke B. Elevated cytosolic Na+ decreases mitochondrial Ca2+ uptake during excitation-contraction coupling and impairs energetic adaptation in cardiac myocytes. Circ Res 2006, 99:172-182.